Earnings Feed
Start Free
Home/Filings/4/0001062993-24-006959
4//SEC Filing

Smith Ernest S. 4

Accession 0001062993-24-006959

CIK 0001205922other
View on SEC.govCompany Profile

Filed

Mar 21, 8:00 PM ET

Accepted

Mar 22, 4:32 PM ET

Size

15.4 KB

Accession

0001062993-24-006959

Insider Transaction Report

Form 4
Period: 2024-03-20
VACCINEX, INC.VCNX
Smith Ernest S.
SVP, Research & CSO
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-03-20+1,341→ 1,341 total
    Exercise: $8.32Exp: 2034-03-20→ Common Stock (1,341 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $83.90Exp: 2033-03-30→ Common Stock (190 underlying)
    190

  • Stock Option (Right to Buy)

    Exercise: $1491.00Exp: 2025-12-22→ Common Stock (193 underlying)
    193

  • Stock Option (Right to Buy)

    Exercise: $819.00Exp: 2029-03-14→ Common Stock (38 underlying)
    38

  • Stock Option (Right to Buy)

    Exercise: $615.30Exp: 2031-04-02→ Common Stock (47 underlying)
    47

  • Common Stock

    39

  • Stock Option (Right to Buy)

    Exercise: $1491.00Exp: 2025-12-23→ Common Stock (24 underlying)
    24

  • Stock Option (Right to Buy)

    Exercise: $270.90Exp: 2032-04-01→ Common Stock (95 underlying)
    95

  • Stock Option (Right to Buy)

    Exercise: $1274.70Exp: 2030-02-24→ Common Stock (38 underlying)
    38
Footnotes (5)
  • [F1]Exercisable in full as of the date of this report.
  • [F2]This option vests one-fourth on each of the first four anniversaries of the April 2, 2021 grant date, except as otherwise provided in the award notice.
  • [F3]This option vests one-fourth on each of the first four anniversaries of the April 1, 2022 grant date, except as otherwise provided in the award notice.
  • [F4]This option vests one-fourth on each of the first four anniversaries of the March 31, 2023 grant date, except as otherwise provided in the award notice.
  • [F5]This option was granted under the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award notice, vests one-fourth on each of the first four anniversaries of the March 20, 2024 grant date.

Documents

1 file

Issuer

VACCINEX, INC.

CIK 0001205922

→
Entity typeother

Related Parties

1
  • filerCIK 0001747769

Filing Metadata

Form type
4
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:32 PM ET
Size
15.4 KB
View on SEC.gov